Restricting analyses of survival to the WCHS Black population only, we observed distinct patterns by breast cancer subtype, and a trend of worse survival with increasing abundance of immune cells for the HER2-positive subgroup. This evidence concerns the gene ERBB2 and breast carcinoma.